Epinastine in the Management of Ocular Allergic Disease
- 1 January 2006
- journal article
- review article
- Published by Ovid Technologies (Wolters Kluwer Health) in International Ophthalmology Clinics
- Vol. 46 (4), 85-86
- https://doi.org/10.1097/01.iio.0000212128.45395.a5
Abstract
No abstract availableThis publication has 7 references indexed in Scilit:
- Histamine receptors and the conjunctivaCurrent Opinion in Allergy and Clinical Immunology, 2005
- Efficacy and Tolerability of Newer Antihistamines in the Treatment of Allergic ConjunctivitisDrugs, 2005
- Efficacy and tolerability of ophthalmic epinastine: A randomized, double-masked, parallel-group, active- and vehicle-controlled environmental trial in patients with seasonal allergic conjunctivitisClinical Therapeutics, 2004
- Efficacy and tolerability of ophthalmic epinastine assessed using the conjunctival antigen challenge model in patients with a history of allergic conjunctivitisClinical Therapeutics, 2004
- Epinastine hydrochloride for atopic diseaseDrugs of Today, 2004
- Effects of cetirizine and epinastine on the skin response to histamine iontophoresisJournal of Dermatological Science, 2001
- A double‐blind, single‐dose, crossover comparison of cetirizine, ebastine, epinastine, fexofenadine, terfenadine, and loratadine versus placebo: suppression of histamine‐induced wheal and flare response for 24 h in healthy male subjectsAllergy, 1999